Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX

Chemico-Biological Interactions

Volumn 187, Issue 1-3, 2010, Pages 249-252

  Lenz, David E ^a   Clarkson, Edward D ^a   Schulz, Susan M ^a   Cerasoli, Douglas M ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Bioscavenger; Butyrylcholinesterase; Nerve agent poisoning; Organophosphorus compound; Therapeutics; VX

Indexed keywords

CHOLINESTERASE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DESIGN; DRUG DOSE COMPARISON; DRUG EFFICACY; GUINEA PIG; IN VIVO STUDY; LD 50; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; SKIN; SURVIVAL RATE;

ANIMALIA; CAPRA HIRCUS; CAVIA; PRIMATES;

EID: 77955514288     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.05.014     Document Type: Article

References (21)

1. Ashani Y., Shapira S., Levy D., Wolfe A.D., Doctor B.P., Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol. 1991, 41:37-41.
2. Broomfield C.A., Maxwell D.M., Solana R.P., Castro C.A., Finger A.V., Lenz D.E. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J. Pharmacol. Exp. Ther. 1991, 259:633-638.
3. Cerasoli D.M., Griffiths E.M., Doctor B.P., Saxena A., Fedorko J.M., Greig N.H., Yu Q.S., Huang Y., Wilgus H., Karatzas C.N., Koplovitz I., Lenz D.E. In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger. Chem. Biol. Interact. 2005, 157:363-365.
4. Cerasoli D.M., Robison C.L., Nwaneri I.Y., Somsamayvong B., Karatzas C.N., Wilgus H., Huang Y., McDonough J.H., Lenz D.E., Lumley L.A. Pretreatment with pegylated Protexia protects against exposure to the nerve agents VX and soman. Abstracts 2005, vol. 31. Society for Neuroscience, 337.19.
5. Doctor B.P., Blick D.W., Caranto G., Castro C.A., Gentry M.K., Larison R., Maxwell D.M., Murphy M.R., Schutz M., Waibel K., Wolfe A.D.A.D. Cholinesterases as scavengers for organophosphorous compounds: protection of primate performance against soman toxicity. Chem. Biol. Interact. 1993, 87:285-293.
6. Doctor B.P., Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem. Biol. Interact. 2005, 157-158:167-171.
7. Lenz D.E., Maxwell D.M., Koplovitz I., Clark C.R., Capacio B.R., Cerasoli D.M., Federko J.M., Luo C., Saxena A., Doctor B.P., Olson C. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem. Biol. Interact. 2005, 157-158:205-210.
8. Lenz D.E., Broomfield C.A., Yeung D.T., Masson P., Maxwell D.M., Cerasoli D.M. Nerve agent bioscavengers; progress in development of a new mode of protection against organophosphorus exposure. Chemical Warfare Agents: Toxicity at Low Levels 2007, 175-202. CRC Press, Boca Raton. 2nd edition. J.A. Romano, B. Lukey, H. Salem (Eds.).
9. Maxwell D.M., Wolfe A.D., Ashani Y., Doctor B.P. Cholinesterase and carboxylesterase as scavengers for organophosphorous agents. Cholinesterases: Structure, Function, Mechanism, Genetics and Cell Biology 1991, 206-209. American Chemical Society, Washington. J. Massoulie, F. Bacou, E. Barnard, A. Chatonnet, B.P. Doctor, D.M. Quinn (Eds.).
10. Raveh L., Grunwald J., Marcus D., Papier Y., Cohen E., Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. Biochem. Pharmacol. 1993, 45:2465-2474.
11. Raveh L., Grauer E., Grunwald J., Cohen E., Ashani Y. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol. Appl. Pharmacol. 1997, 145:43-53.
12. Wolfe A.D., Rush R.S., Doctor B.P., Koplovitz I., Jones D.D. Acetylcholinesterase prophylaxis against organophosphate toxicity. Fund. Appl. Toxicol. 1987, 9:266-270.
13. Wolfe A.D., Blick D.W., Murphy M.R., Miller S.A., Gentry M.K., Hartgraves S.L., Doctor B.P. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol. Appl. Pharmacol. 1992, 117:189-193.
14. Huang Y.-J., Huang Y., Baldassarre H., Wang B., Lazaris A., Leduc M., Bilodeau A.S., Bellemare A., Côté M., Herskovits P., Touati M., Turcotte C., Valeanu L., Lemee N., Wilgus H., Bégin I., Bhatia B., Rao K., Neveu N., Brochu E., Pierson J., Hockley D.K., Cerasoli D.M., Lenz D.E., Karatzas C.N., Langermann S. Recombinant Human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning. Proc. Natl. Acad. Sci. 2007, 104:13603-13608.
15. Huang Y.-J., Lundy P.M., Lazaris A., Huang Y., Baldassarre H., Wang B., Turcotte C., Côté M., Bellemare A., Bilodeau A.S., Brouillard S., Touati M., Herskovits P., Begin I., Neveu N., Brochu E., Pierson J., Hockley D.K., Cerasoli D.M., Lenz D.E., Wilgus H., Karatzas C.N., Langermann S. Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin. BMC Biotechnol. 2008, 8:50.
16. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
17. Barakat N.H., Zheng X., Gilley C.B., MacDonald M., Okolotowicz K., Cashman J.R., Vyas S., Beck J.M., Hadad C.M., Zhang J. Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase. Chem. Res. Toxicol. 2009, 22:1669-1679.
18. Castro C.A., Gresham V.C., Finger A.V., Maxwell D.M., Solana R.P., Lenz D.E., Broomfield C.A. Behavioral decrements persist in rhesus monkeys trained on a serial probe recognition task despite protection against soman lethality by butyrylcholinesterase. Neurotoxicol. Teratol. 1994, 16:145-148.
19. Clarkson E.D., Hackley J.P., Skvorak M., Shutz S., Schulz S., Railer R., Schons M., Macalalag R. Characterization of cutaneous exposure to chemical warfare agents GD, VX and VR. Society for Neuroscience Meeting Abstracts 2001, p. 11 (Abstract #478).
20. Clarkson E.D., Schulz S.M., Railer R.F., Sigler M.A., Logan T.P., Baskin S.I. Cutaneous exposure to GD and VX: Timing of antidotes. The Toxicologist: 45th Annual Meeting and ToxExpo 2006, p. 17 (Abstract #81).
21. Mumford H., Price M.E., Wetherell J.R. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig. J Appl Toxicol. 2008, 28:694-702.